ethosuximide has been researched along with Cancer of Prostate in 1 studies
Ethosuximide: An anticonvulsant especially useful in the treatment of absence seizures unaccompanied by other types of seizures.
ethosuximide : A dicarboximide that is pyrrolidine-2,5-dione in which the hydrogens at position 3 are substituted by one methyl and one ethyl group. An antiepileptic, it is used in the treatment of absence seizures and may be used for myoclonic seizures, but is ineffective against tonic-clonic seizures.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Silvestri, R | 1 |
| Pucci, P | 1 |
| Venalainen, E | 1 |
| Matheou, C | 1 |
| Mather, R | 1 |
| Chandler, S | 1 |
| Aceto, R | 1 |
| Rigas, SH | 1 |
| Wang, Y | 1 |
| Rietdorf, K | 1 |
| Bootman, MD | 1 |
| Crea, F | 1 |
1 other study available for ethosuximide and Cancer of Prostate
| Article | Year |
|---|---|
T-type calcium channels drive the proliferation of androgen-receptor negative prostate cancer cells.
Topics: Calcium Channel Blockers; Calcium Channels, T-Type; Cell Line, Tumor; Cell Proliferation; Ethosuximi | 2019 |